Test the effect of Tab. Thiriphala Chooranam in pre diabetic populatio
Phase 2
- Conditions
- Health Condition 1: null- Impaired Glucose Tolerance (Munnerizhivu)
- Registration Number
- CTRI/2016/10/007396
- Lead Sponsor
- Dr M Kannan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Males or Females with a diagnosis of Impaired Glucose Tolerance (Munnerizhivu).
IGT defined as those patients with Fasting glucose levels -- above 100 mg/dl to within or equal to 125 mg/dl
After 2 hour OGTT -- within 140 mg/dl to 199 mg/dl
Glycated hemoglobin (HbA1C)-- Above 6.0% to within 6.5%
Exclusion Criteria
Subjects with the age below 30 and above 60 years
known Diabetes, Malignant and accelerated hypertensive, Chronic Liver and Renal diseases, Coronary artery disease, Secondary Diabetes mellitus, CNS disorder (e.g. encephalopathy)
Patient undergoing regular treatment for any other severe illness
Pregnant woman and planning to be pregnant within six months and lactating mother
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method During treatment or after treatment OGTT 2 hours result is less than 140 mg/dl, fasting blood sugar is lessthan 100 mg/dl and HbA1c is lessthan or equal to 6.0 % it will be treated as successful outcome of the treatment.Timepoint: 180 Days
- Secondary Outcome Measures
Name Time Method ormal Liver function test and renal function test should be taken as success end point towards safety.Timepoint: 180 Days